Bernard Hoet | Vice President of Medical Strategy
Bavarian Nordic A/S

Bernard Hoet is Vice President, Head of Medical strategy at Bavarian Nordic, a fully integrated pure-play vaccine company. He joined this company early 2020, at the time of acquisition of the rabies and tick-born encephalitis vaccines from GSK, to build up the Medical Affairs department, and rapidly also created the Epidemiology department and then took care of the Clinical Development Strategy department and integrated the Medical Writing department of this company. The mpox outbreak of 2022, the launch of a chikungunya vaccine, and the current mpox outbreak are his main focus activities today, in addition to the development of Bavarian Nordic’s pipeline. Bernard in an MD, FFPM with decades of experience in vaccines Medical Affairs, Pharmacovigilance, Clinical Development, Labeling and Quality Assurance, and has preformed pre-clinical and clinical research previously

Appearances:

Pre-Congress Workshops - 21st April @ 14:00

THE GLOBAL MPOX RESPONSE: Epidemiology, Prevention, and Future Strategies HOSTED BY BAVARIAN NORDIC

The Global Mpox Response: Epidemiology, Prevention, and Future Strategies

Part I: Epidemiology & Mpox in Non-Endemic Countries

Global Mpox Epidemiology: Trends, Insights and Emerging Challenges
The Response to the 2022 Mpox Outbreak in Non-Endemic Countries
Panel Discussion: Mpox in NON-Endemic Countries

Part II: Mpox Response in Endemic Countries

Strengthening Prevention in Endemic Regions: Lessons From the Ground
The Role of MVA-BN in Mpox Management: Current Data and Future Directions
Coordinating the Global Mpox Response Across Different Stakeholders: What Can We Learn From It?
Panel Discussion

Bernard Hoet, Vice President of Medical Strategy, Bavarian Nordic A/S

Boghuma Titanj, Assistant Professor of Medicine, Division of Infectious Diseases, Emory University - School of Medicine

Hypolite Muhindo Mavako, Professor, Department of Tropical Medicine, University of Kinshasa

Rosamund Lewis, Team lead, High threat pathogens, World Health Organization

Main Congress Day 1 - 22nd April @ 11:40

Keynote Panel: Chikungunya - a growing global burden exacerbated by climate change and globalization

Introduction of new vaccines and updating medical practice for Chik control.
How should we define outbreaks and how could we identify and predict hotspots?
How will we meet the demands of more vaccines as climate change drives the need further?
How can data science and digital tools transform climate-sensitive infectious disease modelling and response?

Bernard Hoet, Vice President of Medical Strategy, Bavarian Nordic A/S